Biosimilars may need more time to devleop in the market.
Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.
New changes are making it more difficult for generics and biosimilars to compete on formularies.
First generic specialty injections approved for Novadoz Pharmaceuticals.
Update: now available from three manufacturers.
Xellia Pharmaceuticals will manufacture essential antibiotics for Civica Rx.
Suit filed in Connecticut alleges companies conspired to inflate prices on more than 100 generic drugs.
FDA granted final approval to drug originally tentatively approved in 2018.
The average price of generics is about one-eighteenth the price of the brand product.
Eli Lilly creates generic Humalog priced 50% lower